ACTINIUM PHARMACEUTICALS, INC. Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest
ACTINIUM PHARMACEUTICALS, INC. (ATNM) had Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest of $57.21 million as of 2023-03-31, per its 10-Q filed 2023-05-15.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest · last filed 2023-05-15
- 2023-03-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $57.21M.
- 2022-12-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $66.48M.
- 2022-09-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $71.25M.
- 2022-06-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $78.18M.
| Period end | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest |
|---|---|
| 2023-03-31 | $57.21M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $66.48M 10-Q · filed 2023-05-15 |
| 2022-09-30 | $71.25M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $78.18M 10-Q · filed 2022-11-14 |
| 2022-03-31 | $68.84M 10-Q · filed 2023-05-15 |
| 2021-12-31 | $73.55M 10-Q · filed 2023-05-15 |
| 2021-09-30 | $80.28M 10-Q · filed 2022-11-14 |
| 2021-06-30 | $80.50M 10-Q · filed 2022-11-14 |
| 2021-03-31 | $70.74M 10-Q · filed 2022-11-14 |
| 2020-12-31 | $61.32M 10-K · filed 2023-03-31 |
| 2020-09-30 | $45.43M 10-Q · filed 2021-11-12 |
| 2020-06-30 | $50.77M 10-Q · filed 2021-11-12 |
| 2020-03-31 | $3.02M 10-Q · filed 2021-11-12 |
| 2019-12-31 | $5.64M 10-K · filed 2022-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |